Molecular Diagnosis of Orthopedic-Device-Related Infection Directly from Sonication Fluid by Metagenomic Sequencing

Teresa L Street, Nicholas D Sanderson, Bridget L Atkins, Andrew J Brent, Kevin Cole, Dona Foster, Martin A McNally, Sarah Oakley, Leon Peto, Adrian Taylor, Tim E A Peto, Derrick W Crook, David W Eyre, Teresa L Street, Nicholas D Sanderson, Bridget L Atkins, Andrew J Brent, Kevin Cole, Dona Foster, Martin A McNally, Sarah Oakley, Leon Peto, Adrian Taylor, Tim E A Peto, Derrick W Crook, David W Eyre

Abstract

Culture of multiple periprosthetic tissue samples is the current gold standard for microbiological diagnosis of prosthetic joint infections (PJI). Additional diagnostic information may be obtained through culture of sonication fluid from explants. However, current techniques can have relatively low sensitivity, with prior antimicrobial therapy and infection by fastidious organisms influencing results. We assessed if metagenomic sequencing of total DNA extracts obtained direct from sonication fluid can provide an alternative rapid and sensitive tool for diagnosis of PJI. We compared metagenomic sequencing with standard aerobic and anaerobic culture in 97 sonication fluid samples from prosthetic joint and other orthopedic device infections. Reads from Illumina MiSeq sequencing were taxonomically classified using Kraken. Using 50 derivation samples, we determined optimal thresholds for the number and proportion of bacterial reads required to identify an infection and confirmed our findings in 47 independent validation samples. Compared to results from sonication fluid culture, the species-level sensitivity of metagenomic sequencing was 61/69 (88%; 95% confidence interval [CI], 77 to 94%; for derivation samples 35/38 [92%; 95% CI, 79 to 98%]; for validation samples, 26/31 [84%; 95% CI, 66 to 95%]), and genus-level sensitivity was 64/69 (93%; 95% CI, 84 to 98%). Species-level specificity, adjusting for plausible fastidious causes of infection, species found in concurrently obtained tissue samples, and prior antibiotics, was 85/97 (88%; 95% CI, 79 to 93%; for derivation samples, 43/50 [86%; 95% CI, 73 to 94%]; for validation samples, 42/47 [89%; 95% CI, 77 to 96%]). High levels of human DNA contamination were seen despite the use of laboratory methods to remove it. Rigorous laboratory good practice was required to minimize bacterial DNA contamination. We demonstrate that metagenomic sequencing can provide accurate diagnostic information in PJI. Our findings, combined with the increasing availability of portable, random-access sequencing technology, offer the potential to translate metagenomic sequencing into a rapid diagnostic tool in PJI.

Keywords: diagnosis; metagenomic sequencing; orthopedic device infection; prosthetic joint infection.

Copyright © 2017 Street et al.

Figures

FIG 1
FIG 1
Study samples and quality control. Sequences with

FIG 2

Sequencing data filtering calibration heat…

FIG 2

Sequencing data filtering calibration heat maps. Two thresholds (threshold 1 and threshold 2)…

FIG 2
Sequencing data filtering calibration heat maps. Two thresholds (threshold 1 and threshold 2) and three parameters (parameter a, parameter b, and parameter c) were used to determine true infection. Samples meeting either threshold were determined to be true infection. The final parameter values were chosen by maximizing the Youden index, calculated as follows: (sensitivity + specificity) − 1. For threshold 1, samples with more reads from a given species than an upper-read cutoff (parameter a; plotted on each x axis) were included. For threshold 2, samples with more species-specific reads than a lower-read cutoff (parameter b; the six panels show six different values for parameter b: 50, 100, 125, 150, 200, and 250, which are indicated within each y-axis title) and with the percentage of species-specific reads as a proportion of all bacterial reads present above a percentage cutoff (parameter c, plotted on each y axis) were included.

FIG 3

Sonication culture and sequencing comparison.…

FIG 3

Sonication culture and sequencing comparison. The proportion of sequencing reads classified as bacterial…

FIG 3
Sonication culture and sequencing comparison. The proportion of sequencing reads classified as bacterial is shown on the y axis on a log scale, and the number of CFU from sonication fluid culture is shown on the x axis. Markers are colored by the concordance of sonication fluid culture and sequencing. A single marker is shown per patient sample. Where only one of several species isolated was found by sequencing, this is shown as a false-negative. Similarly, any sample with one or more false-positive species identified by sequencing is shown as false positive. False-negative results where a coagulase-negative Staphylococcus was cultured from sonication fluid but not found in tissue samples or on sequencing are shown separately, as are samples identified only to the genus level by sequencing. Results were very similar if absolute numbers of bacterial reads were plotted on the y axis instead.
FIG 2
FIG 2
Sequencing data filtering calibration heat maps. Two thresholds (threshold 1 and threshold 2) and three parameters (parameter a, parameter b, and parameter c) were used to determine true infection. Samples meeting either threshold were determined to be true infection. The final parameter values were chosen by maximizing the Youden index, calculated as follows: (sensitivity + specificity) − 1. For threshold 1, samples with more reads from a given species than an upper-read cutoff (parameter a; plotted on each x axis) were included. For threshold 2, samples with more species-specific reads than a lower-read cutoff (parameter b; the six panels show six different values for parameter b: 50, 100, 125, 150, 200, and 250, which are indicated within each y-axis title) and with the percentage of species-specific reads as a proportion of all bacterial reads present above a percentage cutoff (parameter c, plotted on each y axis) were included.
FIG 3
FIG 3
Sonication culture and sequencing comparison. The proportion of sequencing reads classified as bacterial is shown on the y axis on a log scale, and the number of CFU from sonication fluid culture is shown on the x axis. Markers are colored by the concordance of sonication fluid culture and sequencing. A single marker is shown per patient sample. Where only one of several species isolated was found by sequencing, this is shown as a false-negative. Similarly, any sample with one or more false-positive species identified by sequencing is shown as false positive. False-negative results where a coagulase-negative Staphylococcus was cultured from sonication fluid but not found in tissue samples or on sequencing are shown separately, as are samples identified only to the genus level by sequencing. Results were very similar if absolute numbers of bacterial reads were plotted on the y axis instead.

References

    1. Lamagni T. 2014. Epidemiology and burden of prosthetic joint infections. J Antimicrob Chemother 69(Suppl 1):i5–i10. doi:10.1093/jac/dku247.
    1. Atkins BL, Athanasou N, Deeks JJ, Crook DW, Simpson H, Peto TE, McLardy-Smith P, Berendt AR. 1998. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol 36:2932–2939.
    1. Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. 2011. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 469:2992–2994. doi:10.1007/s11999-011-2102-9.
    1. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR. 2013. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56:e1–e25. doi:10.1093/cid/cis803.
    1. Bejon P, Berendt A, Atkins BL, Green N, Parry H, Masters S, McLardy-Smith P, Gundle R, Byren I. 2010. Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. J Antimicrob Chemother 65:569–575. doi:10.1093/jac/dkp469.
    1. Tunney MM, Patrick S, Gorman SP, Nixon JR, Anderson N, Davis RI, Hanna D, Ramage G. 1998. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Br 80:568–572. doi:10.1302/0301-620X.80B4.8473.
    1. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, Mandrekar JN, Cockerill FR, Steckelberg JM, Greenleaf JF, Patel R. 2007. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 357:654–663. doi:10.1056/NEJMoa061588.
    1. Piper KE, Jacobson MJ, Cofield RH, Sperling JW, Sanchez-Sotelo J, Osmon DR, McDowell A, Patrick S, Steckelberg JM, Mandrekar JN, Sampedro MF, Patel R. 2009. Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol 47:1878–1884. doi:10.1128/JCM.01686-08.
    1. Achermann Y, Vogt M, Leunig M, Wust J, Trampuz A. 2010. Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. J Clin Microbiol 48:1208–1214. doi:10.1128/JCM.00006-10.
    1. Gomez E, Cazanave C, Cunningham SA, Greenwood-Quaintance KE, Steckelberg JM, Uhl JR, Hanssen AD, Karau MJ, Schmidt SM, Osmon DR, Berbari EF, Mandrekar J, Patel R. 2012. Prosthetic joint infection diagnosis using broad-range PCR of biofilms dislodged from knee and hip arthroplasty surfaces using sonication. J Clin Microbiol 50:3501–3508. doi:10.1128/JCM.00834-12.
    1. Cazanave C, Greenwood-Quaintance KE, Hanssen AD, Karau MJ, Schmidt SM, Gomez Urena EO, Mandrekar JN, Osmon DR, Lough LE, Pritt BS, Steckelberg JM, Patel R. 2013. Rapid molecular microbiologic diagnosis of prosthetic joint infection. J Clin Microbiol 51:2280–2287. doi:10.1128/JCM.00335-13.
    1. Ryu SY, Greenwood-Quaintance KE, Hanssen AD, Mandrekar JN, Patel R. 2014. Low sensitivity of periprosthetic tissue PCR for prosthetic knee infection diagnosis. Diagn Microbiol Infect Dis 79:448–453. doi:10.1016/j.diagmicrobio.2014.03.021.
    1. Fenollar F, Roux V, Stein A, Drancourt M, Raoult D. 2006. Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections. J Clin Microbiol 44:1018–1028. doi:10.1128/JCM.44.3.1018-1028.2006.
    1. Tunney MM, Patrick S, Curran MD, Ramage G, Hanna D, Nixon JR, Gorman SP, Davis RI, Anderson N. 1999. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol 37:3281–3290.
    1. Didelot X, Bowden R, Wilson DJ, Peto TE, Crook DW. 2012. Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet 13:601–612. doi:10.1038/nrg3226.
    1. Lefterova MI, Suarez CJ, Banaei N, Pinsky BA. 2015. Next-generation sequencing for infectious disease diagnosis and management: a report of the Association for Molecular Pathology. J Mol Diagn 17:623–634. doi:10.1016/j.jmoldx.2015.07.004.
    1. Goldberg B, Sichtig H, Geyer C, Ledeboer N, Weinstock GM. 2015. Making the leap from research laboratory to clinic: challenges and opportunities for next-generation sequencing in infectious disease diagnostics. mBio 6:e01888-15. doi:10.1128/mBio.01888-15.
    1. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW. 2014. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 12:87. doi:10.1186/s12915-014-0087-z.
    1. Laurence M, Hatzis C, Brash DE. 2014. Common contaminants in next-generation sequencing that hinder discovery of low-abundance microbes. PLoS One 9:e97876. doi:10.1371/journal.pone.0097876.
    1. Eyre DW, Golubchik T, Gordon NC, Bowden R, Piazza P, Batty EM, Ip CLC, Wilson DJ, Didelot X, O'Connor L, Lay R, Buck D, Kearns AM, Shaw A, Paul J, Wilcox MH, Donnelly PJ, Peto TEA, Walker AS, Crook DW. 2012. A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open 2:e001124. doi:10.1136/bmjopen-2012-001124.
    1. Reuter S, Ellington MJ, Cartwright EJ, Koser CU, Torok ME, Gouliouris T, Harris SR, Brown NM, Holden MT, Quail M, Parkhill J, Smith GP, Bentley SD, Peacock SJ. 2013. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern Med 173:1397–1404. doi:10.1001/jamainternmed.2013.7734.
    1. Didelot X, Eyre DW, Cule M, Ip CLC, Ansari MA, Griffiths D, Vaughan A, O'Connor L, Golubchik T, Batty EM, Piazza P, Wilson DJ, Bowden R, Donnelly PJ, Dingle KE, Wilcox M, Walker AS, Crook DW, Peto TEA, Harding RM. 2012. Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol 13:R118. doi:10.1186/gb-2012-13-12-r118.
    1. Eyre DW, Fawley WN, Best EL, Griffiths D, Stoesser NE, Crook DW, Peto TE, Walker AS, Wilcox MH. 2013. Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission. J Clin Microbiol 51:4141–4149. doi:10.1128/JCM.01095-13.
    1. Walker TM, Lalor MK, Broda A, Ortega LS, Morgan M, Parker L, Churchill S, Bennett K, Golubchik T, Giess AP, Elias CD, Jeffery KJ, Bowler ICJW, Laurenson IF, Barrett A, Drobniewski F, McCarthy ND, Anderson LF, Abubakar I, Thomas HL, Monk P, Smith EG, Walker AS, Crook DW, Peto TEA, Conlon CP. 2014. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study. Lancet Respir Med 2:285–292. doi:10.1016/S2213-2600(14)70027-X.
    1. Stoesser N, Batty EM, Eyre DW, Morgan M, Wyllie DH, Del Ojo Elias C, Johnson JR, Walker AS, Peto TE, Crook DW. 2013. Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J Antimicrob Chemother 68:2234–2244. doi:10.1093/jac/dkt180.
    1. Gordon NC, Price JR, Cole K, Everitt R, Morgan M, Finney J, Kearns AM, Pichon B, Young B, Wilson DJ, Llewelyn MJ, Paul J, Peto TEA, Crook DW, Walker AS, Golubchik T. 2014. Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing. J Clin Microbiol 52:1182–1191. doi:10.1128/JCM.03117-13.
    1. Walker TM, Kohl TA, Omar SV, Hedge J, Del Oji Elias C, Bradley P, Iqbal Z, Feverriegel S, Niehaus KE, Wilson DJ, Clifton DA, Kapatai G, Ip CL, Bowden R, Drobniewski FA, Allix-Beguec C, Gaudin C, Parkhill J, Diet R, Supply P, Crook DW, Smith EG, Walker AS, Ismail N, Niemann S, Petot TEA, Modernizing Medical Microbiology (MMM) Informatics Group. 2015. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 15:1193–1202. doi:10.1016/S1473-3099(15)00062-6.
    1. Li Y, Metcalf BJ, Chochua S, Li Z, Gertz RE Jr, Walker H, Hawkins PA, Tran T, Whitney CG, McGee L, Beall BW. 2016. Penicillin-binding protein transpeptidase signatures for tracking and predicting beta-lactam resistance levels in Streptococcus pneumoniae. mBio 7:e00756-16. doi:10.1128/mBio.00756-16.
    1. Pankhurst LJ, Del Ojo Elias C, Votintseva AA, Walker TM, Cole K, Davies J, Fermont JM, Gascoyne-Binzi DM, Kohl TA, Kong C, Lemaitre N, Niemann S, Paul J, Rogers TR, Roycroft E, Smith EG, Supply P, Tang P, Wilcox MH, Wordsworth S, Wyllie D, Xu L, Crook DW, Compass-TB Study Group . 2016. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Respir Med 4:49–58. doi:10.1016/S2213-2600(15)00466-X.
    1. Hasman H, Saputra D, Sicheritz-Ponten T, Lund O, Svendsen CA, Frimodt-Moller N, Aarestrup FM. 2014. Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples. J Clin Microbiol 52:139–146. doi:10.1128/JCM.02452-13.
    1. Wilson MR, Naccache SN, Samayoa E, Biagtan M, Bashir H, Yu G, Salamat SM, Somasekar S, Federman S, Miller S, Sokolic R, Garabedian E, Candotti F, Buckley RH, Reed KD, Meyer TL, Seroogy CM, Galloway R, Henderson SL, Gern JE, DeRisi JL, Chiu CY. 2014. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med 370:2408–2417. doi:10.1056/NEJMoa1401268.
    1. Naccache SN, Peggs KS, Mattes FM, Phadke R, Garson JA, Grant P, Samayoa E, Federman S, Miller S, Lunn MP, Gant V, Chiu CY. 2015. Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing. Clin Infect Dis 60:919–923. doi:10.1093/cid/ciu912.
    1. Wilson MR, Shanbhag NM, Reid MJ, Singhal NS, Gelfand JM, Sample HA, Benkli B, O'Donovan BD, Ali IK, Keating MK, Dunnebacke TH, Wood MD, Bollen A, DeRisi JL. 2015. Diagnosing Balamuthia mandrillaris encephalitis with metagenomic deep sequencing. Ann Neurol 78:722–730. doi:10.1002/ana.24499.
    1. Kearney MF, Spindler J, Wiegand A, Shao W, Anderson EM, Maldarelli F, Ruscetti FW, Mellors JW, Hughes SH, Le Grice SF, Coffin JM. 2012. Multiple sources of contamination in samples from patients reported to have XMRV infection. PLoS One 7:e30889. doi:10.1371/journal.pone.0030889.
    1. Naccache SN, Greninger AL, Lee D, Coffey LL, Phan T, Rein-Weston A, Aronsohn A, Hackett J Jr, Delwart EL, Chiu CY. 2013. The perils of pathogen discovery: origin of a novel parvovirus-like hybrid genome traced to nucleic acid extraction spin columns. J Virol 87:11966–11977. doi:10.1128/JVI.02323-13.
    1. Votintseva AA, Pankhurst LJ, Anson LW, Morgan MR, Gascoyne-Binzi D, Walker TM, Quan TP, Wyllie DH, Del Ojo Elias C, Wilcox M, Walker AS, Peto TE, Crook DW. 2015. Mycobacterial DNA extraction for whole-genome sequencing from early positive liquid (MGIT) cultures. J Clin Microbiol 53:1137–1143. doi:10.1128/JCM.03073-14.
    1. Wood DE, Salzberg SL. 2014. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol 15:R46. doi:10.1186/gb-2014-15-3-r46.
    1. Ondov BD, Bergman NH, Phillippy AM. 2011. Interactive metagenomic visualization in a Web browser. BMC Bioinformatics 12:385. doi:10.1186/1471-2105-12-385.
    1. Youden WJ. 1950. Index for rating diagnostic tests. Cancer 3:32–35. doi:10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>;2-3.
    1. Portillo ME, Salvadó M, Sorli L, Alier A, Martinez S, Trampuz A, Gómez J, Puig L, Horcajada JP. 2012. Multiplex PCR of sonication fluid accurately differentiates between prosthetic joint infection and aseptic failure. J Infect 65:541–548. doi:10.1016/j.jinf.2012.08.018.

Source: PubMed

3
Abonneren